Abstract
An inpatient palliative care intervention during HCT led to improvement in patient QOL and mood. We sought to describe components of the intervention, investigate differences in supportive care practices by treatment arm, and explore whether these differences mediated the impact of the intervention on patient QOL and mood. We conducted a secondary analysis of a randomized trial investigating inpatient palliative care integrated with transplant care versus standard transplant care for HCT recipients. Palliative care clinicians completed weekly surveys to describe topics addressed during visits. We extracted use of supportive care medications from the medical record. Participants completed QOL and mood assessments at baseline and two weeks post-HCT. Causal mediation assessed whether differences in supportive care practices mediated the impact of the intervention on patient-reported outcomes. A total of 160 HCT recipients participated. Palliative care visits most frequently focused on managing symptoms and coping with HCT. Patients randomized to the intervention were more likely to use Patient-Controlled Analgesia (PCA) (32.1% vs. 15.2%, pā=ā0.02) and atypical antipsychotics (35.8% vs. 17.7%, pā=ā0.01). Neither PCA nor atypical antipsychotics mediated the effect of the intervention on patient-reported outcomes. Future work to explore mechanisms by which the palliative care intervention improves QOL and mood is needed.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Copelan EA. Hematopoietic stem-cell transplantation. N Engl J Med. 2006;354:1813ā26.
Pidala J, Anasetti C, Jim H. Health-related quality of life following haematopoietic cell transplantation: patient education, evaluation and intervention. Br J Haematol. 2010;148:373ā85.
Braamse AMJ, Gerrits MMJG, van Meijel B, Visser O, van Oppen P, Boenink AD, et al. Predictors of health-related quality of life in patients treated with auto- and allo-SCT for hematological malignancies. Bone Marrow Transpl. 2012;47:757ā69.
Andrykowski MA, Bishop MM, Hahn EA, Cella DF, Beaumont JL, Brady MJ, et al. Long-term health-related quality of life, growth, and spiritual well-being after hematopoietic stem-cell transplantation. J Clin Oncol. 2005;23:599ā608.
Anderson KO, Giralt SA, Mendoza TR, Brown JO, Neumann JL, Mobley GM, et al. Symptom burden in patients undergoing autologous stem-cell transplantation. Bone Marrow Transpl. 2007;39:759ā66.
Bevans MF, Mitchell SA, Marden S. The symptom experience in the first 100 days following allogeneic hematopoietic stem cell transplantation (HSCT). Support Care Cancer. 2008;16:1243ā54.
Frƶdin U, Lotfi K, Fomichov V, Juliusson G, Bƶrjeson S. Frequent and long-term follow-up of health-related quality of life following allogeneic haematopoietic stem cell transplantation. Eur J Cancer Care. 2015;24:898ā910.
Mosher CE, Redd WH, Rini CM, Burkhalter JE, DuHamel KN. Physical, psychological, and social sequelae following hematopoietic stem cell transplantation: a review of the literature. Psychooncology 2009;18:113ā27.
Prieto JM, Atala J, Blanch J, Carreras E, Rovira M, Cirera E, et al. Patient-rated emotional and physical functioning among hematologic cancer patients during hospitalization for stem-cell transplantation. Bone Marrow Transpl. 2005;35:307ā14.
El-Jawahri AR, Traeger LN, Kuzmuk K, Eusebio JR, Vandusen HB, Shin JA, et al. Quality of life and mood of patients and family caregivers during hospitalization for hematopoietic stem cell transplantation: QOL and Mood During HCT. Cancer 2015;121:951ā9.
Fife BL, Huster GA, Cornetta KG, Kennedy VN, Akard LP, Broun ER. Longitudinal study of adaptation to the stress of bone marrow transplantation. J Clin Oncol. 2000;18:1539ā49.
El-Jawahri A, Nelson AM, Gray TF, Lee SJ, LeBlanc TW. Palliative and end-of-life care for patients with hematologic malignancies. J Clin Oncol 2020;38:944ā53.
Ruiz M, Reynolds P, Marranzini R, Khan A, Ketterer J, Brahim A. Role of early palliative care interventions in hematological malignancies and bone marrow transplant patients: barriers and potential solutions. Am J Hosp Palliat Care. 2018;35:1456ā60.
Loggers ET, LeBlanc TW, El-Jawahri A, Fihn J, Bumpus M, David J, et al. Pretransplantation supportive and palliative care consultation for high-risk hematopoietic cell transplantation patients. Biol Blood Marrow Transpl. 2016;22:1299ā305.
Levine DR, Baker JN, Wolfe J, Lehmann LE, Ullrich C. Strange bedfellows no more: how integrated stem-cell transplantation and palliative care programs can together improve end-of-life care. J Oncol Pr. 2017;13:569ā77.
El-Jawahri A, LeBlanc T, VanDusen H, Traeger L, Greer JA, Pirl WF, et al. Effect of inpatient palliative care on quality of life 2weeks after hematopoietic stem cell transplantation. JAMA 2016;316:2094ā103.
El-Jawahri A, Traeger L, Greer JA, VanDusen H, Fishman SR, LeBlanc TW, et al. Effect of inpatient palliative care during hematopoietic stem-cell transplant on psychological distress 6 months after transplant: results of a randomized clinical trial. JCO. 2017;35:3714ā21.
McQuellon RP, Russell GB, Cella DF, Craven BL, Brady M, Bonomi A, et al. Quality of life measurement in bone marrow transplantation: development of the Functional Assessment of Cancer Therapy-Bone Marrow Transplant (FACT-BMT) scale. Bone Marrow Transpl. 1997;19:357ā68.
Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67:361ā70.
Ma JD, El-Jawahri AR, LeBlanc TW, Roeland EJ. Pain syndromes and management in adult hematopoietic stem cell transplantation. Hematol/Oncol Clin North Am. 2018;32:551ā67.
Roeland E, Mitchell W, Elia G, Thornberry K, Herman H, Cain J, et al. Symptom control in stem cell transplantation: a multidisciplinary palliative care team approach. Part 1: Physical symptoms. J Support Oncol. 2010;8:100ā16.
Irwin KE, Greer JA, Khatib J, Temel JS, Pirl WF. Early palliative care and metastatic non-small cell lung cancer: potential mechanisms of prolonged survival. Chron Respir Dis. 2013;10:35ā47.
Greer JA, Applebaum AJ, Jacobsen JC, Temel JS, Jackson VA. Understanding and addressing the role of coping in palliative care for patients with advanced cancer. J Clin Oncol. 2020;38:915ā25.
Hoerger M, Greer JA, Jackson VA, Park ER, Pirl WF, El-Jawahri A, et al. Defining the elements of early palliative care that are associated with patient-reported outcomes and the delivery of end-of-life care. JCO. 2018;36:1096ā102.
Greer JA, Jacobs JM, El-Jawahri A, Nipp RD, Gallagher ER, Pirl WF, et al. Role of patient coping strategies in understanding the effects of early palliative care on quality of life and mood. JCO. 2018;36:53ā60.
Kestenbaum A, Shields M, James J, Hocker W, Morgan S, Karve S, et al. What impact do chaplains have? a pilot study of spiritual aim for advanced cancer patients in outpatient palliative care. J Pain Symptom Manag. 2017;54:707ā14.
Acknowledgements
We thank the patients for their participation in this study.
Funding
This work was supported by the National Palliative Care Research Center (El-Jawahri). Dr. El-Jawahri is a Scholar in Clinical Research of the Leukemia and Lymphoma Society. This was also supported by T32 CA092203 (PI: Schrag).
Author information
Authors and Affiliations
Contributions
All authors made substantial contributions to conception and design, acquisition of data, or analysis and interpretation of data. All were involved in drafting the article or revising it critically for important intellectual content. All provided final approval of the manuscript and agree to accountable for all aspects of the work.
Corresponding author
Ethics declarations
Conflict of interest
JAG receives royalties from Springer Humana Press, has research funding from Gaido Health/BCG Digital Ventures, and is a paid consultant from Concerto HealthAI and Blue Note Therapeutics. Other authors have no disclosures.
Additional information
Publisherās note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
About this article
Cite this article
Nelson, A.M., Johnson, P.C., Kavanaugh, A.R. et al. Palliative care for patients undergoing stem cell transplant: intervention components and supportive care measures. Bone Marrow Transplant 56, 1971ā1977 (2021). https://doi.org/10.1038/s41409-021-01281-2
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41409-021-01281-2
This article is cited by
-
Quality of life and symptom burden in hematological cancer patients receiving hematopoietic stem cell transplantation: an observational study at Regional Cancer Centre, India
Supportive Care in Cancer (2024)
-
Advancing Palliative Care Integration in Hematology: Building Upon Existing Evidence
Current Treatment Options in Oncology (2023)
-
Palliative CareĀ ā Konzepte bei hƤmatologischen Patienten
Die Onkologie (2022)